Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: Potential impact for glucotoxicity in vivo

Clinical Endocrinology

Volumn 65, Issue 3, 2006, Pages 301-309

  Lindmark, S ^a   Buren J ^a   Eriksson, J W ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOTROPIN; CYTOKINE; FATTY ACID; HEMOGLOBIN A1C; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NEUTRAL INSULIN; REPAGLINIDE; SULFONYLUREA; TETRACOSACTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOTOXICITY; GLYCEMIC CONTROL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOCORTICOIDS; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; INSULIN RESISTANCE; INTERLEUKIN-6; LINEAR MODELS; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33747346166     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02593.x     Document Type: Article

References (56)

1. DeFronzo, R.A., Bonadonna, R.C. & Ferrannini, E. (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care, 15, 318-368.
2. Alberti, K.G. & Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
3. Elbein, S.C. (1997) The genetics of human noninsulin-dependent (type 2) diabetes mellitus. Journal of Nutrition, 127, 1891S-1896S.
4. Beck-Nielsen, H. & Groop, L.C. (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. Journal of Clinical Investigations, 94, 1714-1721.
5. Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widen, E., Schalin, C. & Groop, L. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New England Journal of Medicine, 321, 337-343.
6. Eriksson, J.W., Smith, U., Waagstein, F., Wysocki, M. & Jansson, P.A. (1999) Glucose turnover and adipose tissue lipolysis are insulinresistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes, 48, 1572-1578.
7. Vestergaard, H., Bjorbaek, C., Andersen, P.H., Bak, J.F. & Pedersen, O. (1991) Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes, 40, 1740-1745.
8. Zierath, J.R., Galuska, D., Nolte, L.A., Thorne, A., Kristensen, J.S. & Wallberg-Henriksson, H. (1994) Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia, 37, 270-277.
9. Jansson, P.A., Eliasson, B., Lindmark, S. & Eriksson, J.W. (2002) Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients - potential role of steroid hormones and leptin in the development of insulin resistance. European Journal of Clinical Investigations, 32, 172-178.
10. Buren, J., Lindmark, S., Renstrom, F. & Eriksson, J.W. (2003) In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism, 52, 239-245.
11. Bjorntorp, P. (1999) Neuroendocrine perturbations as a cause of insulin resistance. Diabetes/Metabolism Research and Reviews, 15, 427-441.
12. Andrews, R.C. & Walker, B.R. (1999) Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science, 96, 513-523.
13. Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K. & Yano, Y. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 83, 859-862.
14. Pickup, J.C., Chusney, G.D., Thomas, S.M. & Burt, D. (2000) Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sciences, 67, 291-300.
15. Kaiser, N., Leibowitz, G. & Nesher, R. (2003) Glucotoxicity and betacell failure in type 2 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism, 16, 5-22.
16. Yki-Jarvinen, H. (1997) Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies. Diabetic Medicine, 14, S32-S37.
17. Lukaski, H.C., Bolonchuk, W.W., Hall, C.B. & Siders, W.A. (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. Journal of Applied Physiology, 60, 1327-1332.
18. Ferrannini, E. & Mari, A. (1998) How to measure insulin sensitivity. Journal of Hypertension, 16, 895-906.
19. DeFronzo, R.A., Tobin, J.D. & Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology, 237, E214-E223.
20. Haffner, S.M., Kennedy, E., Gonzalez, C., Stern, M.P. & Miettinen, H. (1996) A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care, 19, 1138-1141.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
22. Rasmuson, S., Olsson, T. & Hagg, E. (1996) A low-dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology, 44, 151-156.
23. Rask, E., Walker, B.R., Soderberg, S., Livingstone, D.E., Eliasson, M., Johnson, O., Andrew, R. & Olsson, T. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism, 87, 3330-3336.
24. Guechot, J., Fiet, J., Passa, P., Villette, J.M., Gourmel, B., Tabuteau, F., Cathelineau, G. & Dreux, C. (1982) Physiological and pathological variations in saliva cortisol. Hormone Research, 16, 357-364.
25. Hagg, E., Olsson, T. & Grankvist, K. (1990) Salivary cortisol during an overnight dexamethasone suppression test using a simple saliva collection device. Hormone and Metabolic Research, 22, 553-554.
26. Linder, J., Nolgard, P., Nasman, B., Back, O., Uddhammar, A. & Olsson, T. (1993) Decreased peripheral glucocorticoid sensitivity in Alzheimer's disease. Gerontology, 39, 200-206.
27. Walker, B.R. (1996) Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocrine Research, 22, 701-708.
28. Taskinen, M.R. (2005) Type 2 diabetes as a lipid disorder. Current Molecular Medicine, 5, 297-308.
29. Golay, A., Swislocki, A.L., Chen, Y.D. & Reaven, G.M. (1987) Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and noninsulin-dependent diabetic individuals. Metabolism, 36, 692-696.
30. Coppack, S.W. (2001) Pro-inflammatory cytokines and adipose tissue. Proceedings of the Nutrition Society, 60, 349-356.
31. Friedman, T.C., Mastorakos, G., Newman, T.D., Mullen, N.M., Horton, E.G., Costello, R., Papadopoulos, N.M. & Chrousos, G.P. (1996) Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocrine Journal, 43, 645-655.
32. Jessop, D.S., Dallman, M.F., Fleming, D. & Lightman, S.L. (2001) Resistance to glucocorticoid feedback in obesity. Journal of Clinical Endocrinology and Metabolism, 86, 4109-4114.
33. Ljung, T., Andersson, B., Bengtsson, B.A., Bjorntorp, P. & Marin, P. (1996) Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Research, 4, 277-282.
34. Rask, E., Olsson, T., Soderberg, S., Andrew, R., Livingstone, D.E., Johnson, O. & Walker, B.R. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. Journal of Clinical Endocrinology and Metabolism, 86, 1418-1421.
35. Cotter, P.A., Mulligan, O.F., Landau, S., Papadopoulos, A., Lightman, S.L. & Checkley, S.A. (2002) Vasoconstrictor response to topical beclomethasone in major depression. Psychoneuroendocrinology, 27, 475-487.
36. Bruun, J.M., Lihn, A.S., Verdich, C., Pedersen, S.B., Toubro, S., Astrup, A. & Richelsen, B. (2003) Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. American Journal of Physiology. Endocrinology and Metabolism, 285, E527-E533.
37. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature, 389, 610-614.
38. Sethi, J.K. & Hotamisligil, G.S. (1999) The role of TNF alpha in adipocyte metabolism. Seminars in Cell and Developmental Biology, 10, 19-29.
39. Hotamisligil, G.S. (1999) Mechanisms of TNF-alpha-induced insulin resistance. Experimental and Clinical Endocrinology and Diabetes, 107, 119-125.
40. Judd, A.M., Call, G.B., Barney, M., McIlmoil, C.J., Balls, A.G., Adams, A. & Oliveira, G.K. (2000) Possible function of IL-6 and TNF as intra-adrenal factors in the regulation of adrenal steroid secretion. Annals of the New York Academy of Sciences, 917, 628-637.
41. Tomlinson, J.W., Moore, J., Cooper, M.S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M. & Stewart, P.M. (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology, 142, 1982-1989.
42. Turnbull, A.V. & Rivier, C. (1995) Regulation of the HPA axis by cytokines. Brain, Behavior and Immunity, 9, 253-275.
43. Frohlich, M., Imhof, A., Berg, G., Hutchinson, W.L., Pepys, M.B., Boeing, H., Muche, R., Brenner, H. & Koenig, W. (2000) Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care, 23, 1835-1839.
44. Temelkova-Kurktschiev, T., Henkel, E., Koehler, C., Karrei, K. & Hanefeld, M. (2002) Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance. Diabetologia, 45, 151.
45. Scholin, A., Siegbahn, A., Lind, L., Berne, C., Sundkvist, G., Bjork, E. & Karlsson, F.A. (2004) CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes. Diabetes/Metabolism Research and Reviews, 20, 205-210.
46. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., Nakamura, T., Tochino, Y., Funahashi, T. & Matsuzawa, Y. (2002) Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 51, 2734-2741.
47. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E. & Tataranni, P.A. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 86, 1930-1935.
48. Salans, L.B., Cushman, S.W. & Weismann, R.E. (1973) Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. Journal of Clinical Investigations, 52, 929-941.
49. Stern, J.S., Batchelor, B.R., Hollander, N., Cohn, C.K. & Hirsch, J. (1972) Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet, 2, 948-951.
50. Weyer, C., Foley, J.E., Bogardus, C., Tataranni, P.A. & Pratley, R.E. (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia, 43, 1498-1506.
51. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P. & Bahouth, S.W. (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 145, 2273-2282.
52. Seckl, J.R. & Walker, B.R. (2001) Mini review: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376.
53. Lindmark, S., Lonn, L., Wiklund, U., Tufvesson, M., Olsson, T. & Eriksson, J.W. (2005) Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obesity Research, 13, 717-728.
54. Petersen, K.F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G.I. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New England Journal of Medicine, 350, 664-671.
55. Lin, Y., Berg, A.H., Iyengar, P., et al. (2004) The hyperglycemiainduced inflammatory response in adipocytes: the role of reactive oxygen species. Journal of Biological Chemistry, 280, 4617-4626.
56. Krogh-Madsen, R., Moller, K., Dela, F., Kronborg, G., Jauffred, S. & Pedersen, B.K. (2004) Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. American Journal of Physiology. Endocrinology and Metabolism, 286, E766-E772.